 Becton Dickinson shares rose 5.40, or 2.3, to 250.61 in early trading. The authorization was based on a robust sample size of 226 specimens from sites across the United States, Evercore ISI analyst Vijay Kumar said in a research note. We think the new antigen test will play a big role in the coming flu season as a rapid, rule out test, Kumar said. 